VIMAC Early Stage Fund

VIMAC Ventures is a venture capital firm based in Boston, Massachusetts, that specializes in early-stage investments within the life sciences, healthcare, and information technology sectors. Founded in 1982, the firm has historically managed several funds, including the VIMAC Early Stage Fund and the VIMAC Milestone Medica Fund, focusing on biotechnology and drug discovery technologies. VIMAC's investment strategy typically targets Series A and Series B rounds, providing capital and strategic guidance to startups in the eastern United States and Canada. The firm's life sciences portfolio has included companies such as Angiochem, Fennec Pharma, and Rapid Micro Biosystems. Although the firm was a significant player in the early 2000s biotech venture scene, its primary funds are now liquidated, and the firm is currently inactive.